Professor Josephine Forbes from Mater Research-UQ in Queensland, is the current President of the Australian Diabetes Society advocating and supporting better and more equitable health care and research funding for people with diabetes. Her translational research extends from bench to bedside for novel therapies to prevent type 1 diabetes and kidney disease in vulnerable groups including youth and those who identify as Aboriginal and Torres Strait Islander Peoples.

Justine Cain has led Diabetes Australia as Group Chief Executive Officer since 2021. Ms Cain has held senior executive and Board roles with listed, privately owned, private equity-backed and not-for-profit organisations in the health, human services and general insurance sectors. Justine is currently on the Board of UnitingCare Queensland. Justine’s expertise spans transformational leadership roles, strategy development and execution, customer-centric leadership, large-scale operational delivery, government relations, advocacy and complex stakeholder management. Justine is committed to achieving equity in access to health services, population health improvement and judicious use of funding. Justine holds a Bachelor of Laws and a Bachelor of Science from the Australian National University. Justine has undertaken executive education at both Harvard and Insead and is a member of Chief Executive Women and the Australian Institute of Company Directors. In June 2025, Justine’s leadership in the health sector was recognised by the Australian Financial Review Women in Leadership Awards with Justine being a finalist in the health services category.

Professor Josephine Forbes from Mater Research-UQ in Queensland, is the current President of the Australian Diabetes Society advocating and supporting better and more equitable health care and research funding for people with diabetes. Her translational research extends from bench to bedside for novel therapies to prevent type 1 diabetes and kidney disease in vulnerable groups including youth and those who identify as Aboriginal and Torres Strait Islander Peoples.

Professor Cheung is the Director of Diabetes & Endocrinology at Westmead Hospital. He has served as President of the Australian Diabetes Society, Chairperson of the National Association of Diabetes Centres, a board member of Diabetes Australia, and as Foundation Chair of the Medical, Education and Scientific Committee of the National Diabetes Services Scheme. He is currently Co-chair of the Endocrine Network of the NSW Agency for Clinical Innovation Inpatient diabetes management and diabetes in pregnancy are his key areas of clinical and research interest. He is heavily involved in the implementation of evidence-based guidelines for diabetes.

Stephen Colagiuri is Professor Emeritus and Co-Director of the WHO Collaborating Centre on Physical Activity, Nutrition and Obesity, Charles Perkins Centre and Faculty of Medicine and Health, University of Sydney. His research focus is evidence-based diabetes prevention and care. He served as Vice-President (Physician) on the Board of the International Diabetes Federation (2017 to 2022) and on a number of WHO technical advisory groups. He is a member of the IDF Obesity Taskforce.

Professor Josephine Forbes from Mater Research-UQ in Queensland, is the current President of the Australian Diabetes Society advocating and supporting better and more equitable health care and research funding for people with diabetes. Her translational research extends from bench to bedside for novel therapies to prevent type 1 diabetes and kidney disease in vulnerable groups including youth and those who identify as Aboriginal and Torres Strait Islander Peoples.

Prof. Spiros Fourlanos is Director of the Royal Melbourne Hospital Department of Diabetes & Endocrinology and based at the University of Melbourne. His doctoral thesis was on ‘Latent Autoimmune Diabetes in Adults (LADA): New Clinical, Immunogenetic and Metabolic Perspectives’. Spiros is an author on 190 peer-reviewed publications and has been an investigator in over 35 randomised clinical trials. His areas of interest include type 1 diabetes, atypical forms of diabetes and inpatient diabetes care. He is currently a co-stream lead in the University of Melbourne Australian Centre for Accelerating Diabetes Innovations (ACADI) collaborative and co-chair of the ADS In-Hospital Diabetes sub-committee.

Matt is an endocrinologist and clinician-researcher whose work focuses on understanding and addressing the intergenerational epidemic of diabetes and related conditions among Aboriginal and Torres Strait Islander peoples. This work is conducted in partnership with community members, people with lived experience and health services. Matt is Staff Specialist and Clinical Lead for Remote Services within the Endocrinology Department at Royal Darwin Hospital and Senior Research Fellow at Menzies School of Health Research. He currently serves as President of the Australasian Diabetes in Pregnancy Society and is heavily involved in guideline development and advocacy for people and communities affected by diabetes.